Financing type:  bought deal short form prospectus offering

Gross proceeds:  $34,500,276

Offering:  22,697,550 listed shares

Offering price:  $1.52 per listed share

Overallotment option:  The agents may purchase a maximum of 2,960,550 listed shares for overallotment purposes, at any time until 30 days following the closing date. As of Aug. 6, 2026, such option has been fully exercised. All information presented herein includes such exercise.

Disclosure:  Refer to the prospectus dated July 31, 2026, and the company's news releases dated July 20, 2026, July 31, 2026, and Aug. 6, 2026.